Endometrial cancer is a common gynecological malignancy in women. The common method is surgical treatment, but the chance of recurrence after treatment is very high. So how can we prevent recurrence? The recurrence of endometrial cancer after surgery is mainly because the surgery cannot completely remove the cancer, and the residual cancer cells revive. Therefore, the use of CLS biological immunotherapy to completely remove cancer cells in the body can effectively prevent recurrence. How to avoid recurrence of endometrial cancer after surgery Wu: There are currently two main postoperative treatments for endometrial cancer, one is systemic chemotherapy and the other is CLS biological immunotherapy. The former is the most common treatment method. Because of its good effect, it has become the first choice for postoperative treatment of many cancers, but it will have strong side effects for some patients, so the choice needs to be cautious. However, the other CLS biological immunotherapy is a new type of therapy, which has recently been included in the fourth largest tumor treatment technology in my country, on par with surgery, radiotherapy, and chemotherapy. It is very simple to treat, only a certain amount of peripheral blood is drawn from the patient, the cells are separated, stimulated, and proliferated in the laboratory, and the strengthened immune cells are re-infused into the patient's body to quickly strengthen the patient's immune function and gain the ability to eliminate cancer cells throughout the body. More advantages than traditional therapies, biological immunotherapy is better for treating cancer 1. Wide range of applications: biological immunotherapy covers almost all tumor types. 2. The therapeutic effect is good, and it has obvious therapeutic effects on both primary tumors and metastatic tumors. 3. It is more effective than radiotherapy and chemotherapy in removing residual tumor cells after surgery and preventing tumor metastasis and recurrence. 4. The side effects are small. Currently, only side effects such as fever and cold have been found. 5. It does not damage normal tissues and can enhance the body's immunity and improve physical condition. Biological cell therapy is effective in treating tumors and is favored by many patients Biological cell immunotherapy is the fourth largest tumor treatment technology after surgery, radiotherapy and chemotherapy. The treatment effect of this therapy is remarkable and has caused a strong response in the entire medical community. In my country, there are not many diagnostic and treatment institutions that can truly implement biological cell immunotherapy. According to clinical findings, biological cell immunotherapy is the use of high-end biological cell technology in the laboratory to activate and culture a large number of cancer-killing immune cells, enabling them to have the ability to efficiently identify and kill cancer cells, and then return them to the patient's body to achieve the purpose of treating tumors and inhibit the metastasis and recurrence of cancer cells. This method achieves the purpose of treating tumors without destroying the function of the body's immune system, and is also the best way to treat tumors. |
<<: Late recurrence of endometrial cancer
>>: How to treat endometrial cancer in ancient times
There are many types of complementary foods that ...
As a common disease, rectal cancer can seriously ...
Venous blockage is a serious disease, but it usua...
After women reach adulthood, they should have a f...
Many people experience neck pain after sleeping. ...
Good sleep quality is very important for people...
Lung cancer is a highly prevalent malignant tumor...
Endometrial cancer is a disease that seriously en...
Spinal tumor refers to a tumor occurring in the s...
In daily life, we need to pay attention to change...
China's drinking culture has a long history. ...
Ovarian cancer has the characteristics of insidio...
It is generally recommended to go to the hospital...
There are a small amount of sweat hair distribute...
Cervical cancer is not cancer at the beginning. I...